Lung Kee Group Holdings Limited to Hold Board Meeting on 20 March 2026

Key Points for Investors

• Scheduled Board Meeting: Lung Kee Group Holdings Limited (“the Company”) has announced that its Board of Directors will convene a meeting on Friday, 20 March 2026 at 2:00 p.m. The meeting will take place at Unit A, 15th Floor, Kings Wing Plaza 2, No.1 On Kwan Street, Sha Tin, New Territories, Hong Kong.
• Approval of Final Results: A major agenda item for this meeting is the approval of the final results of the Company and its subsidiaries for the financial year ended 31 December 2025. This is a key financial milestone that provides a comprehensive overview of the Company’s performance for the year.
• Dividend Recommendation: The Board will also consider recommending the payment of a final dividend to shareholders. This is particularly significant for investors, as any decision regarding dividend payouts can have a direct impact on share valuation and investor returns.

Potential Price-Sensitive Information

• Release of Financial Results: The announcement and subsequent publication of the Company’s audited results for the year ended 2025 is an event that can influence investor sentiment and share price, as it will reflect the financial health and profitability of the Group.
• Dividend Decision: Any recommendation or declaration regarding the final dividend is of particular interest to shareholders. Changes in dividend policy, increase or decrease in the proposed dividend, or a surprise decision can all significantly affect the share price.

Additional Details

• Executive Leadership: As of the date of this announcement, the Company’s executive directors are Mr. Siu Tit Lung (Chairman), Mr. Siu Yuk Lung, Mr. Wai Lung Shing, Mr. Ting Chung Ho, Mr. Siu Yuk Tung, Ivan, and Mr. Siu Yu Hang, Leo.
• Independent Non-Executive Directors: The independent non-executive directors are Dr. Lee Tat Yee, Mr. Wong Hak Kun, and Ms. He Lamei.
• Official Communication: The announcement was signed by Mr. Wai Lung Shing, Director and Company Secretary, and dated 5 March 2026, in Hong Kong, China.
• Company Website: Further information about the Company can be found at http://www.irasia.com/listco/hk/lkm.

Implications for Shareholders

Investors should pay close attention to the outcomes of the upcoming board meeting. The approval and publication of the final results, coupled with any announcement regarding the final dividend, are likely to be closely watched by the market. These factors can directly influence the valuation of Lung Kee Group Holdings Limited’s shares. Shareholders are advised to monitor subsequent announcements closely for further details on the Company’s performance and any declared dividends.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should consult with their financial advisers and review official company disclosures before making any investment decisions. The author and publisher accept no liability for any actions taken based on the information provided above.

View LUNG KEE Historical chart here